InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Perraton, Matthew Thomas. Director active across 1 company, notably Theralase Technologies Inc.. Cumulatively, 1 disclosures have been logged. Activity tracked since 7 August 2026. The latest transaction was disclosed on 7 August 2026 (50 - Grant of options). Regulator: SEDI. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration